TY - JOUR T1 - Strategies for communicating health evidence to health policymakers and the population. Scoping review protocol JF - medRxiv DO - 10.1101/2021.11.04.21265922 SP - 2021.11.04.21265922 AU - Ana Luiza Cabrera Martimbianco AU - Rafael Leite Pacheco AU - Ângela Maria Bagattini AU - Roberta de Fátima Carreira Moreira AU - Rachel Riera Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/11/04/2021.11.04.21265922.abstract N2 - Evidence-based health information is provided by evidence synthesis and health technology assessments. Nevertheless, this information is complex for public understanding, pointing to the need to disseminate clearly. This scoping review aims to identify different strategies for communicating health evidence to policymakers and the general population. A scoping review will be conducted following the Joanna Briggs Institute Manual for Scoping Reviews. This comprehensive mapping will contribute to identifying the literature on health evidence-based information, identify the most appropriate approaches for each audience, and the literature gaps to guide future studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Programa de Apoio ao Desenvolvimento Institucional do Sistema Unico de Saude (PROADI-SUS)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors ER -